Prosecutorial Perspectives on Recent Settlements, OIG’s Guidance, and Enforcement Priorities for 2021
March 18, 2021 • 1:45 pm
Practical Analysis of a Game Changer: Interpreting the November 2020 Special Fraud Alert on Speaker Programs
March 18, 2021 • 1:00 pm
The Real-Life Lessons from the Novartis, Gilead, and Biogen Settlements: Key Liability Risks Relating to Speaker and Patient Assistance Programs
March 18, 2021 • 2:45 pm
Perspectives on Staying Compliant in the Context of the Pandemic, Managing Interactions with HCPs, and Keeping up with Evolving Regulatory Requirements
March 18, 2021 • 4:15 pm
What the Newest AKS Safe Harbors Mean for Pharmaceutical and Medical Device Manufacturers
March 18, 2021 • 5:15 pm
Receive exclusive discounts, offers and agenda updates directly to your inbox.